propranolol has been researched along with nortriptyline in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (32.61) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 10 (21.74) | 29.6817 |
| 2010's | 14 (30.43) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Gabriel, E; Karobath, M; Lenz, G | 1 |
| Prusiner, S; Raskin, NH | 1 |
| Banaszkiewicz, W; Grzymislawska, I; Mrozikiewica, A | 1 |
| Bertilsson, L; Kaneko, S; Otani, K | 1 |
| Badia, A; Sallés, J; Vila, E | 1 |
| Brockmeier, D; Ostrowski, J | 1 |
| McMahon, T | 1 |
| Goldstein, FJ; Malseed, RT; Rossi, GV | 1 |
| Carrara, C; Garattini, S; Jori, A; Paglialunga, S | 1 |
| Garattini, S; Jori, A; Paglialunga, S | 1 |
| Thorstrand, C | 1 |
| Riegelman, S | 1 |
| König, J; Mlejnková, M; Rysánek, K; Spánková, H; Synek, P | 1 |
| Gaffney, TE; Knapp, D; Privitera, P; Saelens, D; Walle, T | 1 |
| Oates, JA; Shand, DG | 1 |
| Hillard, JR; Vieweg, WV | 1 |
| Neppe, VM | 1 |
| Cosbey, SH; Craig, I; Gill, R | 1 |
| Iruela, LM | 1 |
| Abel, EL | 1 |
| Fragala, MR; Richmond, DR; Sabaawi, M | 1 |
| Aquino, CC; Domingues, RB; Domingues, SA; Kuster, GW; Silva, AL | 1 |
| Furutani, K; Inanobe, A; Kurachi, Y; Ohno, Y; Yamakawa, Y | 1 |
| Atzori, M; Basu, D; Dinh, L; Nichols, JA; Peña-Contreras, Z; Roychowdhury, S; Tam, J; Yadlapalli, A | 1 |
| Donaldson, L; Dornhoffer, JR; Liu, YF; Macias, D; Rizk, HG | 1 |
2 review(s) available for propranolol and nortriptyline
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for propranolol and nortriptyline
| Article | Year |
|---|---|
A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Migraine Disorders; Nortriptyline; Propranolol; Treatment Outcome | 2009 |
43 other study(ies) available for propranolol and nortriptyline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine | 1976 |
Carotidynia.
Topics: Adult; Aged; Carotid Artery Diseases; Dose-Response Relationship, Drug; Ergonovine; Female; Headache; Humans; Jaw Diseases; Methysergide; Middle Aged; Migraine Disorders; Nortriptyline; Pain; Propranolol | 1977 |
Influence of some antidepressant drugs on the circulatory system: II. Action of amitriptyline and nortriptyline on basic circulatory parameters.
Topics: Amitriptyline; Animals; Atropine; Cats; Dihydroergotamine; Hemodynamics; In Vitro Techniques; Muscle, Smooth; Myocardial Contraction; Norepinephrine; Nortriptyline; Propranolol; Quaternary Ammonium Compounds; Rabbits; Respiration | 1975 |
Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.
Topics: Animals; Biological Transport, Active; Brain; Disease Models, Animal; Kidney; Male; Metabolic Clearance Rate; Nortriptyline; Propranolol; Quinidine; Rats; Rats, Inbred Strains | 1991 |
Effects of chronic antidepressant treatment on alpha 1- and alpha 2-adrenoceptors in the rat anococcygeus muscle.
Topics: Animals; Antidepressive Agents; Cocaine; Desipramine; Electric Stimulation; Male; Mianserin; Muscle Contraction; Muscles; Nomifensine; Normetanephrine; Nortriptyline; Phenylephrine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Xylazine | 1990 |
Mean time and first-pass metabolism.
Topics: Humans; Models, Biological; Molsidomine; Nortriptyline; Pharmaceutical Preparations; Propranolol; Regression Analysis; Sydnones; Time Factors | 1985 |
Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol.
Topics: Bipolar Disorder; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; Nortriptyline; Pargyline; Proline; Propranolol; Substance Withdrawal Syndrome | 1985 |
Potentiation of monoaminergic activity in peripheral ganglia by tricyclic antidepressants.
Topics: Action Potentials; Animals; Antidepressive Agents; Cats; Desipramine; Dibenzocycloheptenes; Dopamine; Drug Synergism; Epinephrine; Ganglia; Norepinephrine; Nortriptyline; Propranolol; Serotonin; Synaptic Transmission; Time Factors | 1972 |
Pharmacological studies on modaline sulphate (w 3207).
Topics: Antidepressive Agents; Desipramine; Dibenzylchlorethamine; Dihydroxyphenylalanine; Fever; Hydrazines; Isoproterenol; Monoamine Oxidase Inhibitors; Nortriptyline; Phentolamine; Proadifen; Propranolol; Reserpine; Sympatholytics; Tryptamines | 1965 |
Effect of antidepressant and adrenergic blocking drugs on hyperthermia induced by reserpine.
Topics: Amitriptyline; Animals; Antidepressive Agents; Atropine; Body Temperature; Chlorisondamine; Chlorpromazine; Desipramine; Ethanolamines; Female; Fever; Hydrazines; Imipramine; Monoamine Oxidase Inhibitors; Norepinephrine; Nortriptyline; Phenoxybenzamine; Phentolamine; Propranolol; Rats; Reserpine; Sympatholytics; Tetrabenazine | 1967 |
Cardiovascular effects of poisoning with tricyclic antidepressants.
Topics: Adult; Amitriptyline; Blood; Blood Pressure; Body Temperature; Carbon Dioxide; Cardiac Output; Coma; Depression, Chemical; Electrocardiography; Female; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nortriptyline; Oxygen; Oxygen Consumption; Partial Pressure; Positive-Pressure Respiration; Propranolol; Stimulation, Chemical; Suicide; Time Factors | 1974 |
Physiological and pharmacokinetic complexities in bioavailability testing.
Topics: Administration, Oral; Animals; Autoradiography; Biopharmaceutics; Carbon Isotopes; Cats; Diazepam; Dosage Forms; Half-Life; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestines; Kinetics; Male; Mice; Nortriptyline; Propranolol; Quinidine; Radiography; Solubility; Stomach; Tetracycline; Time Factors; Water | 1972 |
Relationship between substances strengthening of the thrombocyte cell membrane on the aggregation of thrombocytes and on the uptake and release of serotonin.
Topics: Adenosine Diphosphate; Amitriptyline; Benzothiepins; Blood Platelets; Cell Membrane; Cell Membrane Permeability; Chlorpromazine; Colorimetry; Desipramine; Epinephrine; Humans; Imipramine; In Vitro Techniques; Nortriptyline; Phentolamine; Piperazines; Platelet Adhesiveness; Propranolol; Receptors, Adrenergic; Serotonin; Serotonin Antagonists; Spectrometry, Fluorescence; Tranquilizing Agents | 1972 |
The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man.
Topics: Animals; Biotransformation; Chromatography, Gas; Computers; Humans; Isotopes; Mass Spectrometry; Nortriptyline; Pharmaceutical Preparations; Propranolol; Research Design | 1974 |
Metabolism of propranolol by rat liver microsomes and its inhibition by phenothiazine and tricyclic antidepressant drugs.
Topics: Amitriptyline; Animals; Antidepressive Agents; Chlorpromazine; Desipramine; Imipramine; Kinetics; Liver; Male; Metabolism; Microsomes, Liver; NAD; NADP; Nitrogen; Nortriptyline; Perphenazine; Phenothiazines; Prochlorperazine; Promazine; Promethazine; Propranolol; Rats; Subcellular Fractions; Trifluoperazine; Triflupromazine | 1971 |
Marked sinus tachycardia resulting from the synergistic effects of marijuana and nortriptyline.
Topics: Adult; Dronabinol; Drug Synergism; Female; Humans; Marijuana Abuse; Nortriptyline; Propranolol; Tachycardia | 1983 |
Propranolol, depression, and nortriptyline interaction.
Topics: Depressive Disorder; Drug Interactions; Humans; Nortriptyline; Propranolol | 1984 |
Novel solid-phase extraction strategy for the isolation of basic drugs from whole blood. Preliminary study using commercially available extraction cartridges.
Topics: Adsorption; Animals; Blood Chemical Analysis; Cation Exchange Resins; Chromatography; Gas Chromatography-Mass Spectrometry; Imipramine; Nortriptyline; Pharmaceutical Preparations; Propranolol; Quinine; Sheep; Solubility | 1995 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Aspirin; Chest Pain; Coronary Disease; Depression; Humans; Male; Middle Aged; Nortriptyline; Propranolol; Sertraline | 1994 |
Alpha-adrenergic receptors mediate imipramine/alarm substance-induced reaction in rats.
Topics: Animals; Arousal; Brain; Citalopram; Clonidine; Dose-Response Relationship, Drug; Imipramine; Male; Norepinephrine; Nortriptyline; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-2; Receptors, GABA; Reserpine; Serotonin; Yohimbine | 1994 |
Akathisia in association with nortriptyline therapy.
Topics: Adult; Aged; Akathisia, Drug-Induced; Female; Humans; Male; Nortriptyline; Propranolol | 1993 |
Pharmacophore modeling for hERG channel facilitation.
Topics: Animals; Atenolol; Chlorpheniramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoxetine; Haloperidol; Humans; Hydrophobic and Hydrophilic Interactions; Imipramine; Metoprolol; Nortriptyline; Potassium Channel Blockers; Promethazine; Propranolol; Quantitative Structure-Activity Relationship; Sotalol; Terfenadine; Verapamil; Xenopus laevis | 2012 |
α₂- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Animals; Attention; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Norepinephrine; Nortriptyline; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Time Factors; Yohimbine | 2012 |
Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine.
Topics: Adult; Aged; Aged, 80 and over; Botulinum Toxins; Dizziness; Female; Humans; Injections; Male; Middle Aged; Migraine Disorders; Nortriptyline; Propranolol; Retrospective Studies; Risk Factors; Topiramate; Treatment Failure; Verapamil; Young Adult | 2020 |